Alivus Life Sciences Approves Equity Allotment Under ESOP Scheme 2021
Alivus Life Sciences Ltd 路 Others (Uncategorized) 路 30 Oct 2026, 1:27 am
Alivus Life Sciences Approves Equity Allotment Under ESOP Scheme 2021 On 29th Oct'26, the Board of Directors of Alivus Life Sciences approved the allotment of 1,95,833 equity shares of face value Rs. 2 each following the exercise of stock options under the Employee Stock Option Scheme, 2021. Consequently, the company's paid-up share capital expanded from 12,27,71,448 shares (Rs. 24,55,42,896) to 12,29,67,281 shares (Rs. 24,59,34,562).
Original exchange filing (PDF)
More announcements from Alivus Life Sciences Ltd
- Enclosed please find herewith update on acquisition. 路 11 Nov 2026
- Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR), 2015. 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma Ltd 路 07 Nov 2026
- Please find attached herewith submission with respect to transcript of the earning call. 路 06 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor meeting. 路 04 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor Meet. 路 30 Oct 2026
- We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30, 2026 on the website of the Company. 路 30 Oct 2026
- Please find enclosed herewith Investor Presentation for Q2 FY26-27. 路 30 Oct 2026
